The Role of Iron in Neurodegeneration: Prospects for Pharmacotherapy of Parkinson's Disease

ISSN： 1170-229X

Source： Drugs & Aging, Vol.14, Iss.2, 1999-02, pp. : 115-140

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of LRRK2 in Neurodegeneration of Parkinson Disease

Current Neuropharmacology, Vol. 16, Iss. 9, 2018-11 ,pp. : 1348-1357

Bentham Science Publishers

Access to resources Recommend Favorite

Parkinson's disease: emerging pharmacotherapy

By Strecker Karl Schwarz Johannes

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 4, 2008-12 ,pp. : 573-591

Informa Healthcare

Access to resources Recommend Favorite

Role of nitric oxide in a progressive neurodegeneration model of Parkinson's disease in the rat

By Barthwal M.K. Srivastava N. Dikshit M.

Redox Report, Vol. 6, Iss. 5, 2001-10 ,pp. : 297-302

Maney Publishing

Access to resources Recommend Favorite

The Paths to Neurodegeneration in Genetic Parkinson's Disease

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 9, 2014-11 ,pp. : 1485-1512

Bentham Science Publishers

Access to resources Recommend Favorite

Rasagiline in the pharmacotherapy of Parkinson’s disease – a review

By Rascol Olivier

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 12, 2005-10 ,pp. : 2061-2075

Informa Healthcare

Access to resources Recommend Favorite